本文選題：丹毒　切入點(diǎn)：下肢　出處：《中國(guó)全科醫(yī)學(xué)》2017年S2期

【摘要】：目的探討中西醫(yī)結(jié)合治療丹毒的臨床療效,為丹毒患者的治療提供科學(xué)指導(dǎo)和理論基礎(chǔ)。方法對(duì)江橋鎮(zhèn)社區(qū)衛(wèi)生服務(wù)中心2014—2016年期間收治的140例丹毒患者,隨機(jī)分為聯(lián)合治療組、清熱解毒組、止痛消腫組和常規(guī)治療組,每組各35例。聯(lián)合治療組以中藥外用內(nèi)服結(jié)合青霉素治療;清熱解毒組中藥內(nèi)服結(jié)合青霉素治療;止痛消腫以中藥外用結(jié)合青霉素治療;常規(guī)治療組以硫酸鎂外敷結(jié)合青霉素治療,并對(duì)4組患者的療效進(jìn)行比較分析。結(jié)果隨訪半年內(nèi),聯(lián)合治療組比常規(guī)治療組、清熱解毒組和止痛消腫組的復(fù)發(fā)率低、總有效率高(P0.05)。治療后5 d,聯(lián)合治療組比常規(guī)治療組、止痛消炎組的附近淋巴結(jié)數(shù)量少、體溫低,比常規(guī)治療組、清熱解毒組與止痛消腫組的白細(xì)胞計(jì)數(shù)(WBC)低、皮溫評(píng)分低,比常規(guī)治療組的附近淋巴結(jié)壓痛評(píng)分低(P0.05)。治療后10 d,聯(lián)合治療組比常規(guī)治療組、清熱解毒組和止痛消腫組的附近淋巴結(jié)數(shù)量少,比止痛消腫組的WBC低;聯(lián)合治療組、清熱解毒組比常規(guī)治療組的WBC低、局部皮溫評(píng)分低;聯(lián)合治療組、清熱解毒組比常規(guī)治療組的附近淋巴結(jié)壓痛評(píng)分低,聯(lián)合治療組比止痛消腫組的附近淋巴結(jié)壓痛評(píng)分低,止痛消腫組比常規(guī)治療組的附近淋巴結(jié)壓痛評(píng)分低(P0.05)。各組治療后5 d、10 d比治療前的附近淋巴結(jié)數(shù)量少、體溫均低、WBC低、局部皮溫評(píng)分低、附近淋巴結(jié)壓痛評(píng)分低(P0.05)。結(jié)論在對(duì)丹毒患者進(jìn)行治療的過(guò)程中,選用中藥內(nèi)服外敷結(jié)合青霉素靜脈滴注治療的方式,能收到良好的治療效果,且治愈時(shí)間短,是一種較為理想的治療方式。對(duì)于丹毒臨床治療具有重要意義,值得大力推廣。
[Abstract]:Objective to explore the clinical efficacy of integrated traditional Chinese and western medicine in the treatment of erysipelas and to provide scientific guidance and theoretical basis for the treatment of erysipelas.Methods 140 cases of erysipelas in Jiangqiao Town Community Health Service Center from 2014-2016 were randomly divided into three groups: combined treatment group, heat-clearing and detoxifying group, analgesic and detumescent group and routine treatment group, with 35 cases in each group.The combined treatment group was treated with external Chinese medicine and penicillin; the heat-clearing and detoxifying group was treated with Chinese medicine combined with penicillin; the pain relief and detumescence was treated with traditional Chinese medicine combined with penicillin; and the routine treatment group was treated with magnesium sulfate combined with penicillin.The curative effects of 4 groups were compared and analyzed.Results within half a year, the recurrence rate of the combined treatment group was lower than that of the routine treatment group, the heat-clearing and detoxifying group and the analgesic and detumescent group, and the total effective rate was higher than that of the conventional treatment group (P 0.05).5 days after treatment, the number of adjacent lymph nodes and hypothermia in the combined treatment group were lower than those in the conventional treatment group and the analgesic and anti-inflammatory group, and the WBCcount was lower and the skin temperature score was lower than that in the conventional treatment group, the heat-clearing and detoxifying group and the analgesic and detumescent group.The tenderness score of adjacent lymph nodes in the routine treatment group was lower than that in the conventional treatment group (P 0.05).At 10 days after treatment, the number of adjacent lymph nodes in the combined treatment group was lower than that in the conventional treatment group, the heat clearing and detoxification group and the analgesic and detumescent group, and the WBC was lower in the combined treatment group than in the conventional treatment group, and the local skin temperature score was lower in the combined treatment group than in the conventional treatment group.In the combined treatment group, the tenderness score of the adjacent lymph nodes in the combined treatment group was lower than that in the conventional treatment group, the tenderness score in the combined treatment group was lower than that in the analgesic and detumescent group, and the tenderness score in the analgesic and detoxifying group was lower than that in the conventional treatment group (P 0.05).Five days after treatment, the number of lymph nodes was less than that before treatment, the body temperature was low and WBC was low, the local skin temperature score was low, and the nearby lymph node tenderness score was lower than that before treatment (P 0.05).Conclusion in the course of treatment of erysipelas patients, it is an ideal treatment way to choose the traditional Chinese medicine internal and external application combined with penicillin intravenous drip to treat the patients with erysipelas, it can get good therapeutic effect, and the cure time is short.The clinical treatment of erysipelas is of great significance and worth popularizing.
【作者單位】： 上海市嘉定區(qū)江橋鎮(zhèn)社區(qū)衛(wèi)生服務(wù)中心;
【基金】：上海市科委市級(jí)課題《中藥外用內(nèi)服結(jié)合青霉素靜脈滴注治療下肢丹毒的療效研究》(20134176)
【分類(lèi)號(hào)】：R753.5

【相似文獻(xiàn)】

相關(guān)期刊論文 前10條

1 ;“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2009年08期

2 ;“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2009年03期

3 ;“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2009年04期

4 ;“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2009年06期

5 ;“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2009年09期

6 ;“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2009年10期

7 ;第二屆“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑耐ㄖ猍J];中國(guó)骨與關(guān)節(jié)損傷雜志;2010年07期

8 ;第一屆“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑墨@獎(jiǎng)名單[J];中國(guó)骨與關(guān)節(jié)損傷雜志;2010年02期

9 ;第一屆“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑墨@獎(jiǎng)名單[J];中國(guó)骨與關(guān)節(jié)損傷雜志;2010年07期

10 ;第一屆“奇正杯”止痛消腫外用藥臨床應(yīng)用有獎(jiǎng)?wù)魑墨@獎(jiǎng)名單[J];中國(guó)骨與關(guān)節(jié)損傷雜志;2010年08期

，

本文編號(hào)：1723099